Ramoplanin, a potent cyclic lipoglycodepsipeptide antibiotic, has been reported to be active against aerobic and anaerobic gram-positive bacteria. Mechanistic studies show that Ramoplanin prevents cell wall peptidoglygan formation and further enzymatic processing via binding to lipid II, a key intermediate moeity. Ramoplanin has also displayed a low affinity for Lipid I, a substrate for the MurG step of cell wall formation.
规格
英文别名
Glycolipodepsi peptide antibiotic produced by actinoplanes species ATCC33076 | A 16686 | Ramoplanin [USAN:INN] | A 16686A | UNII-0WX9996O2G | Antibiotic A 16686 | NSC 760084 | 0WX9996O2G | Antibiotic A 16686, 2-(((3alpha,5beta)-3-hydroxy-7,24-dioxocholan-